Effectiveness of abdominal hollowing and piriformis stretching exercises in spondylolisthesis patients: a study protocol for a randomized controlled trial Authors: Ganesh Dey, Mohammad Anwar Hossain, Polok Halder, Md. Nazmul Huda, Mithun Adhikari, Fabiha Alam Published: 2026 ABSTRACT BackgroundLumbar spondylolisthesis is a clinically important cause of chronic low back pain, activity limitation, and reduced functional capacity. Exercise-based physiotherapy is widely recommended for conservative management, yet uncertainty remains regarding the added value of targeted core stabilization and hip-related stretching strategies in this population. Abdominal hollowing is intended to improve deep trunk muscle activation and lumbopelvic control, whereas piriformis stretching may reduce posterior hip tightness and movement-related discomfort. This trial aims to evaluate whether adding abdominal hollowing and piriformis stretching exercises to a standardized conventional physiotherapy programme improves pain, functional disability, and kinesiophobia in adults with low-grade lumbar spondylolisthesis.MethodsThis study is a two-arm, parallel group, assessor-blinded randomized controlled superiority trial. Seventy-two participants aged 18 to 65 years with radiologically confirmed lumbar spondylolisthesis of Meyerding grade I or II, chronic localized low back pain of more than 3 months, and a baseline pain intensity of more than 3 on a 10-point Visual Analogue Scale will be recruited from the Musculoskeletal Physiotherapy Unit of the Centre for the Rehabilitation of the Paralysed, Savar, Bangladesh. Recruitment is planned from April 2026 to June 2026. Participants will be allocated in a 1:1 ratio using a computer-generated block randomization sequence with concealed allocation. Both groups will receive a standardized conventional physiotherapy programme three times weekly for 6 weeks. The experimental group will additionally receive abdominal hollowing and piriformis stretching exercises. The primary outcome will be pain intensity measured by the 10-cm Visual Analogue Scale immediately after the 6-week intervention. Secondary outcomes will include functional disability measured by the Oswestry Disability Index, kinesiophobia measured by the Tampa Scale for Kinesiophobia, and all outcome measures assessed at 4-week follow-up. Data will be analysed according to the intention-to-treat principle using linear mixed effects models, with effect estimates reported alongside 95% confidence intervals.DiscussionThis trial will determine whether adding targeted core stabilization and piriformis stretching to a standardized physiotherapy programme produces superior short-term clinical outcomes in people with lumbar spondylolisthesis. The findings may inform conservative rehabilitation strategies for this population, particularly in resource-limited clinical settings.Trial registrationClinical Trial Registry India (CTRI), CTRI/2025/07/089927. Registered prospectively on 01 July 2025.Supplementary InformationThe online version contains supplementary material available at https://doi.org/10.1186/s13063-026-09873-3. Background Low back pain is one of the most common musculoskeletal disorders worldwide and remains a major cause of disability, healthcare use, work limitation, and reduced quality of life [1, 2]. Among the structural conditions associated with persistent low back pain, lumbar spondylolisthesis is clinically important because it may alter spinal alignment, increase mechanical stress, and restrict physical function [3, 4]. Spondylolisthesis refers to the anterior displacement of one vertebra relative to the vertebra below it and most commonly affects the lumbar spine. It may arise from degenerative, isthmic, traumatic, dysplastic, or pathological causes, with degenerative changes, segmental instability, increasing age, female sex, and repetitive spinal loading recognized as important risk factors [3, 5]. Although many individuals with low-grade lumbar spondylolisthesis can be managed non-surgically, the optimal content of conservative physiotherapy remains uncertain [4, 6]. Current non-operative care commonly includes education, activity modification, medication support, and exercise therapy, but exercise prescriptions vary substantially across studies and clinical settings [4, 6]. In particular, it remains unclear whether adding targeted deep core activation and specific hip-related stretching strategies to a standardized physiotherapy programme provides clinically meaningful benefit beyond conventional exercise-based care alone [7, 8]. Core stabilization is relevant in lumbar spondylolisthesis because impaired control of the deep trunk musculature may reduce segmental support and increase pain-provoking mechanical stress [4, 9]. Abdominal hollowing is intended to facilitate activation of the transversus abdominis and related local stabilizing muscles while minimizing unnecessary dominance of superficial trunk muscles [9, 10]. In addition, lumbar stability is influenced by coordinated activity of the multifidus, diaphragm, and pelvic floor, which together contribute to trunk stiffness and pressure regulation during movement [4, 9]. Piriformis-related tightness may further aggravate pain, alter pelvic mechanics, and limit functional movement. Biomechanical studies of the deep external rotators suggest that specific hip positions can meaningfully lengthen these structures, providing a rationale for targeted stretching within lumbopelvic rehabilitation programmes [11, 12]. Evidence from low back pain populations also suggests that combining core and hip-focused exercise approaches may improve pain and physical function [13]. Previous research has highlighted important gaps in the rehabilitation literature for lumbar spondylolisthesis. Existing trials have often compared broad stabilization programmes with general exercise, with inconsistent findings and limited detail regarding exercise progression, treatment fidelity, and the contribution of specific programme components [7, 8]. Psychological factors have also received comparatively less attention, despite evidence that fear of movement may influence activity avoidance, disability, and rehabilitation response in chronic low back pain [14, 15]. Kinesiophobia is therefore a clinically relevant outcome in this trial because persistent pain and perceived instability may discourage movement, reduce exercise adherence, and limit functional recovery even when structural pathology is low grade [7, 15]. Against this background, the present trial will evaluate whether adding abdominal hollowing and piriformis stretching exercises to a standardized conventional physiotherapy programme is more effective than the same standardized programme alone in adults with low-grade lumbar spondylolisthesis. The study will also describe participant demographic and clinical characteristics and examine between-group and within-group changes in pain intensity, functional disability, and kinesiophobia after a 6-week intervention and short-term follow-up. It is hypothesized that participants receiving the additional targeted exercise programme will demonstrate greater improvements in pain, disability, and fear of movement than those receiving standardized conventional physiotherapy alone. Methods/design Study design This study will be a two-arm, parallel group, assessor-blinded randomized controlled superiority trial conducted at the Musculoskeletal Physiotherapy Unit of the Centre for the Rehabilitation of the Paralysed, Savar, Dhaka, Bangladesh. Participant recruitment is planned from April 2026 to June 2026. Because the intervention period lasts 6 weeks and includes a 4-week follow-up, final outcome collection is expected to continue beyond the recruitment window. Participants will be randomly allocated in a 1:1 ratio to either an experimental group or a control group. Both groups will receive a standardized conventional physiotherapy programme, while the experimental group will additionally receive abdominal hollowing and piriformis stretching exercises. Outcomes will be assessed at baseline, immediately after the 6-week intervention period, and at 4-week follow-up. The primary objective is to determine whether the addition of the targeted exercise programme results in superior improvement in pain intensity, measured by the 10-cm Visual Analogue Scale immediately after the 6-week intervention. Secondary objectives are to compare functional disability, kinesiophobia, and all outcomes assessed at 4-week follow-up between the two groups. The protocol has been developed in accordance with SPIRIT 2025 recommendations, and reporting of the eventual trial results will follow CONSORT 2025 guidance. Study setting The study will be conducted at the Musculoskeletal Physiotherapy Unit of the Centre for the Rehabilitation of the Paralysed, Savar, Dhaka, Bangladesh. This unit provides outpatient physiotherapy services for patients with a wide range of musculoskeletal disorders and receives referrals from diverse socioeconomic and geographic backgrounds, thereby offering a clinically relevant setting for evaluating conservative management of lumbar spondylolisthesis. Study population The study population will consist of adults aged 18 to 65 years with radiologically confirmed lumbar spondylolisthesis of Meyerding grade I or II who present with chronic localized low back pain and are referred for outpatient physiotherapy management at the study site. Sample size calculation The sample size was calculated using G Power software version 3.1.9.7 for a repeated measures comparison between two groups across three assessment points. The calculation was informed by previously published stabilization exercise trials in comparable lumbar spondylolysis and spondylolisthesis populations and assumed a moderate between-group effect size of 0.65 for the primary pain outcome, reflecting a clinically meaningful difference in pain reduction between treatment groups, with a two-sided alpha level of 0.05 and statistical power of 80% [7, 8]. On this basis, 60 participants with complete data are required. To account for an anticipated attrition rate of 20%, the recruitment target was inflated to 72 participants, resulting in a planned sample of 36 participants in each group. Recruitment and screening procedures Participants will be recruited from the Musculoskeletal Physiotherapy Unit of the Centre for the Rehabilitation of the Paralysed, Savar, Dhaka, Bangladesh, between April 2026 and June 2026. Potentially eligible individuals will be identified by a research assistant and screened according to predefined inclusion and exclusion criteria. The recruitment process will proceed as follows. First, potentially eligible patients will be approached and provided with verbal and written information about the study. Second, those willing to participate will undergo eligibility screening, including review of radiographic confirmation, clinical presentation, and baseline pain intensity. Third, written informed consent will be obtained by a trained research assistant before any study specific procedure is performed. The research assistant will explain the study purpose, procedures, potential benefits and risks, confidentiality arrangements, voluntary participation, and the right to withdraw without affecting routine clinical care. Fourth, baseline assessments will be completed by an assessor blinded to treatment allocation. Finally, participants will be randomized to one of the two trial groups using the concealed allocation process described below. Eligibility criteria The inclusion and exclusion criteria for participant selection will ensure that only individuals meeting the necessary conditions are enrolled in the study. The criteria are as follows. Inclusion criteria Participants will be included if they meet the following criteria: (1) age between 18 and 65 years; (2) radiologically confirmed lumbar spondylolisthesis of Meyerding grade I or II; (3) chronic localized low back pain persisting for more than 3 months; (4) baseline pain intensity greater than 3 on a 10-point Visual Analogue Scale; (5) Oswestry Disability Index score of at least 20%; (6) ability to understand study procedures and provide written informed consent; and (7) willingness to attend supervised treatment sessions and comply with the protocol. Exclusion criteria Participants will be excluded if they meet any of the following criteria: (1) previous spinal surgery; (2) current participation in another structured exercise or rehabilitation programme for low back pain; (3) severe neurological deficit or progressive neurological signs; (4) pregnancy; (5) serious spinal pathology, including spinal malignancy, spinal infection, fracture, tuberculosis, or cauda equina syndrome; (6) severe psychiatric disorder or cognitive impairment that may compromise informed consent, safety, adherence, or outcome reporting; and (7) any medical condition that makes participation in exercise unsafe in the judgement of the principal investigator. Withdrawal criteria Participants may be withdrawn from the study if they request withdrawal, develop a serious adverse event, become medically ineligible to continue, demonstrate repeated non-attendance that prevents completion of the intervention, or begin another treatment that could substantially interfere with trial outcomes. Data collected up to the time of withdrawal will be retained unless the participant requests otherwise, in accordance with ethical approval and consent procedures. Sampling technique and randomization A consecutive sampling approach will be used to recruit eligible participants from the study site during the recruitment period. After baseline assessment, participants will be randomized in a 1:1 ratio to either the experimental group or the control group. The allocation sequence will be generated by an independent research assistant using a computer-generated block randomization schedule with variable block sizes. Allocation concealment will be ensured using sequentially numbered, opaque, sealed envelopes prepared in advance by a team member not involved in recruitment, treatment delivery, or outcome assessment. Following confirmation of eligibility and completion of baseline assessment, the next envelope in sequence will be opened to determine group allocation. Each participant will be assigned a unique study identification code to maintain confidentiality and to support secure data management throughout the trial. Personnel involved in participant enrolment, eligibility screening, baseline assessment, and intervention delivery will not have access to the random allocation sequence. The complete allocation sequence will be retained only by the independent research assistant who prepares the sequentially numbered, opaque, sealed envelopes and who is not involved in recruitment, treatment delivery, or outcome assessment. Group assignment will be revealed only after eligibility confirmation, written informed consent, and completion of baseline assessment. Blinding Because of the nature of the exercise interventions, treating physiotherapists and participants cannot be fully blinded to treatment allocation. Accordingly, this trial will be described as assessor-blinded rather than single blind. To reduce expectation-related bias, participants will be informed that the study compares two active physiotherapy programmes, but they will not be told the specific study hypothesis regarding the superiority of one programme over the other. Outcome assessments will be performed by physiotherapists who are not involved in treatment delivery and who will remain unaware of group allocation throughout the study. The statistician will analyse coded group data without access to the allocation key until the primary analyses are complete. To minimize therapist-related performance bias, all treating physiotherapists will receive standardized training before participant enrolment, will follow a written treatment manual, and will complete treatment fidelity checklists after each session. Where more than one therapist is involved, therapists will be balanced across groups as far as practicable, and regular monitoring meetings will be held to ensure protocol adherence [16]. Emergency unblinding procedures are not required because participants and treating physiotherapists will not be blinded to treatment allocation. Outcome assessors and the statistician will remain blinded, and allocation codes will not be released to them until the primary analyses are complete. Details of the intervention All participants will receive supervised physiotherapy three times per week for 6 weeks, resulting in a total of 18 treatment sessions. Each session will last approximately 30 to 40 min. To reduce treatment heterogeneity and improve interpretability of the trial, the conventional physiotherapy programme will be standardized across groups and will not include discretionary manual therapy, spinal manipulation, or electrotherapy during the trial period, consistent with calls for clearer comparator definition in rehabilitation trial protocols [4, 16] (Table 1). Table 1Summary of trial interventionsGroupComponentDosageFrequencyDurationProgressionBoth groupsEducation and activity modificationBrief structured sessionEvery supervised visit5 to 10 minReinforced according to symptomsBoth groupsGentle lumbar and pelvic mobility1 to 2 sets of 10 reps3 times weekly6 weeksWithin symptom toleranceBoth groupsGeneral flexibility exercises3 repetitions per stretch3 times weekly6 weeksIncreased stretch toleranceBoth groupsLow-load trunk and hip strengthening2 sets of 10 reps3 times weekly6 weeksProgressed by control and toleranceExperimental onlyAbdominal hollowing2 sets of 10 reps, 10 s holds3 times weekly6 weeksCrook lying to sitting to standingExperimental onlyPiriformis stretching3 repetitions, 20 to 30 s holds3 times weekly6 weeksBased on flexibility and symptoms Table 1Summary of trial interventionsGroupComponentDosageFrequencyDurationProgressionBoth groupsEducation and activity modificationBrief structured sessionEvery supervised visit5 to 10 minReinforced according to symptomsBoth groupsGentle lumbar and pelvic mobility1 to 2 sets of 10 reps3 times weekly6 weeksWithin symptom toleranceBoth groupsGeneral flexibility exercises3 repetitions per stretch3 times weekly6 weeksIncreased stretch toleranceBoth groupsLow-load trunk and hip strengthening2 sets of 10 reps3 times weekly6 weeksProgressed by control and toleranceExperimental onlyAbdominal hollowing2 sets of 10 reps, 10 s holds3 times weekly6 weeksCrook lying to sitting to standingExperimental onlyPiriformis stretching3 repetitions, 20 to 30 s holds3 times weekly6 weeksBased on flexibility and symptoms Summary of trial interventions Standardized conventional physiotherapy programme for both groups Both groups will receive the same standardized conventional physiotherapy programme consisting of education regarding posture, activity modification, pacing, and avoidance of fear-driven inactivity, gentle lumbar and pelvic mobility exercises within symptom tolerance, general flexibility exercises for major lumbopelvic and lower limb muscle groups, low-load trunk and hip strengthening exercises progressed according to symptom tolerance, and a simple home exercise programme that mirrors the assigned supervised exercises [4, 6]. Experimental group Participants allocated to the experimental group will receive the standardized conventional physiotherapy programme plus abdominal hollowing and piriformis stretching exercises. Abdominal hollowing Abdominal hollowing will initially be taught in crook lying. Participants will be instructed to gently draw the lower abdominal wall inward without pelvic tilting, rib flaring, or breath holding, while maintaining relaxed upper trunk activity. Correct performance will be confirmed by verbal and visual feedback from the treating physiotherapist. During weeks 1 and 2, the exercise will be performed in crook lying. From weeks 3 and 4, it will progress to sitting. From weeks 5 and 6, it will progress to standing and simple functional positions as tolerated. Each contraction will be held for 10 s, with 10 repetitions per set and 2 sets per session, separated by a 30-s rest interval. This approach is consistent with literature supporting abdominal hollowing as a method for emphasizing deep local stabilizing muscle activation and improving trunk control [9, 10]. Piriformis stretching Piriformis stretching will be performed in a standardized supine position. The participant will be instructed to move the hip into flexion, adduction, and external rotation to the point of a tolerable stretch without provoking marked symptoms. Each stretch will be held for 20 to 30 s and repeated 3 times on the symptomatic side, or bilaterally when symptoms are bilateral. Stretch intensity will remain within symptom tolerance, and progression will be based on improved flexibility and reduced discomfort over time. The chosen stretching rationale is supported by biomechanical work demonstrating meaningful length changes in the short external rotators in flexed and adducted hip positions and by related clinical literature linking hip stretching with functional improvement in low back pain populations [11–13]. Control group Participants allocated to the control group will receive only the standardized conventional physiotherapy programme. They will not receive abdominal hollowing or piriformis stretching as part of the supervised intervention. Progression and adherence Exercise progression will be individualized according to symptom response, movement quality, and tolerance. Progression criteria will include the ability to complete the prescribed repetitions without compensatory movement, marked increase in pain, or excessive fatigue. Attendance will be recorded at each supervised session. Participants in both groups will receive a home programme logbook, and adherence will be reviewed weekly. To preserve a focused comparison and minimize treatment heterogeneity between groups, abdominal bracing, diaphragm-specific training, and iliopsoas stretching were not included as separate intervention components in the present protocol. Concomitant care Participants will be asked not to begin any new structured physiotherapy, chiropractic treatment, spinal manipulation, manual therapy, electrotherapy, injection therapy, or other exercise-based rehabilitation programme for low back pain during the 6-week intervention and 4-week follow-up period. Routine medical care and previously prescribed medications will be permitted if clinically required, but any medication use, additional treatment, or change in usual care will be recorded at each assessment and considered during interpretation of the findings. Participants who receive additional treatments that may substantially affect trial outcomes will not be withdrawn automatically, but the deviation will be documented and included in sensitivity analysis where appropriate. Outcome measures Assessments will be performed at baseline, immediately after the 6-week intervention period, and at 4-week follow-up by an assessor blinded to group allocation. Primary outcome Pain intensity Pain intensity will be assessed using a 10-cm Visual Analogue Scale. Participants will indicate their average low back pain intensity over the previous week, with higher scores indicating greater pain. The Visual Analogue Scale is one of the most widely used measures of pain intensity in low back pain research and has demonstrated acceptable validity, responsiveness, and clinical utility in musculoskeletal populations [17]. Secondary outcomes Functional disability Functional disability will be assessed using the Oswestry Disability Index. The Oswestry Disability Index is a widely used condition-specific questionnaire for low back-related disability, with higher scores indicating greater activity limitation, and it has demonstrated strong validity, reliability, and clinical usefulness in spine-related research and practice [18, 19]. Kinesiophobia Kinesiophobia will be assessed using the Tampa Scale for Kinesiophobia. This questionnaire evaluates fear of movement or reinjury, with higher scores indicating greater fear avoidance. Prior studies have supported its construct validity, internal consistency, and psychometric usefulness in populations with chronic low back pain [14, 20]. Kinesiophobia will also be assessed at baseline before randomization in all enrolled participants and will be analysed as a continuous outcome variable; no minimum Tampa Scale for Kinesiophobia threshold will be required for study entry. Baseline descriptive variables Sociodemographic and clinical data will be collected at baseline using a structured questionnaire. Variables will include age, sex, occupation, educational status, residence, marital status, smoking status, body mass index, symptom duration, and comorbidities. Study procedure and data collection methods After screening and informed consent, eligible participants will complete a baseline assessment. Randomization will occur only after all baseline measures have been recorded. Participants will then receive their allocated intervention for 6 weeks. Outcome measures will be collected at three time points: baseline before the start of treatment, immediately after completion of the 6-week intervention, and at 4-week follow-up. This schedule aligns with SPIRIT 2025 expectations for the clear presentation of enrolment, intervention, and assessment time points in trial protocols [16]. All data collection forms will be checked on the day of assessment for completeness and consistency. Data will be entered into a password-protected electronic database using double-entry procedures. The final analytical dataset will contain only de-identified participant codes. Table 2 presents the SPIRIT schedule of enrolment, interventions, and assessments for the trial. Table 2SPIRIT schedule of enrolment, interventions, and assessmentsStudy periodScreeningBaselineWeeks 1 to 6Post-intervention4-week follow-upEligibility screeningXInformed consentXDemographic and clinical dataXRandomizationXStandardized conventional physiotherapyXAbdominal hollowing and piriformis stretchingXVisual Analogue ScaleXXXOswestry Disability IndexXXXTampa Scale for KinesiophobiaXXXAdverse event monitoringXXXHome exercise adherence reviewXXX Table 2SPIRIT schedule of enrolment, interventions, and assessmentsStudy periodScreeningBaselineWeeks 1 to 6Post-intervention4-week follow-upEligibility screeningXInformed consentXDemographic and clinical dataXRandomizationXStandardized conventional physiotherapyXAbdominal hollowing and piriformis stretchingXVisual Analogue ScaleXXXOswestry Disability IndexXXXTampa Scale for KinesiophobiaXXXAdverse event monitoringXXXHome exercise adherence reviewXXX SPIRIT schedule of enrolment, interventions, and assessments Participant retention and follow-up To promote retention, participants will receive clear information about the visit schedule before enrolment, appointment reminders before supervised sessions and outcome assessments, and flexible scheduling within clinic capacity. Missed treatment sessions will be recorded, and participants will be contacted to arrange the next available session whenever possible. Participants who discontinue the allocated intervention, miss sessions, or deviate from the intervention protocol will still be invited to complete all outcome assessments at the scheduled post-intervention and 4-week follow-up time points. For such participants, VAS, ODI, TSK, adverse events, medication use, and any additional treatment received during the trial period will be collected whenever possible. Data management All study data will be handled in de-identified form using unique participant study codes. Paper records will be stored in locked cabinets accessible only to authorized study personnel. Electronic files will be stored on password-protected computers and backed up on secure institutional systems. Data entry will be completed independently by two trained personnel members, and discrepancies will be resolved through comparison with the original source documents. Access to the final de-identified dataset will be limited to the principal investigator, designated data manager, and statistician. Any protocol deviations, missing data patterns, and adverse event records will be documented prospectively throughout the trial. Statistical analysis All statistical analyses will be performed using SPSS version 25.0 or an equivalent statistical package. Analyses will follow the intention-to-treat principle. Baseline characteristics will be summarized using means and standard deviations for approximately normally distributed continuous variables, medians and interquartile ranges for skewed continuous variables, and frequencies with percentages for categorical variables. The primary analysis will examine change in VAS pain intensity from baseline to immediately after the 6-week intervention between the two groups using a linear mixed effects model with fixed effects for group, time, and the group-by-time interaction. Secondary analyses will examine functional disability, kinesiophobia, and all outcomes assessed at 4-week follow-up using the same modelling approach. Participant-level random effects will be included to account for repeated measurements within individuals. The primary parameter of interest will be the group-by-time interaction. Normality of model residuals will be assessed using the Shapiro-Wilk test and inspection of Q-Q plots. Homogeneity of variance will be assessed using Levene’s test where appropriate. If substantial violations of model assumptions are detected, appropriate non-parametric or robust alternatives will be considered and reported. Effect estimates will be presented with 95% confidence intervals, and standardized effect sizes will also be calculated. A per-protocol sensitivity analysis will be conducted for participants with satisfactory treatment adherence. Missing data will be handled using likelihood-based estimation within the mixed-model framework, or, where necessary, by multiple imputation. Statistical significance will be set at p less than 0.05 (Table 3). A separate statistical analysis plan has not been prepared. The planned statistical methods are described in this protocol before completion of participant recruitment and data analysis. Table 3Planned statistical analysisOutcomeData typeMain analysisAssumption checksAdditional reportingVAS pain intensityContinuousLinear mixed effects modelShapiro-Wilk, Q-Q plot, Levene’s testMean difference, 95% CI, effect sizeODIContinuousLinear mixed effects modelShapiro-Wilk, Q-Q plot, Levene’s testMean difference, 95% CI, effect sizeTSKContinuousLinear mixed effects modelShapiro-Wilk, Q-Q plot, Levene’s testMean difference, 95% CI, effect sizeBaseline categorical variablesCategoricalChi-square or Fisher’s exact testNot applicableFrequencies and percentagesBaseline continuous variablesContinuousIndependent t-test or Mann-Whitney U testDistribution assessmentMeans or medians Table 3Planned statistical analysisOutcomeData typeMain analysisAssumption checksAdditional reportingVAS pain intensityContinuousLinear mixed effects modelShapiro-Wilk, Q-Q plot, Levene’s testMean difference, 95% CI, effect sizeODIContinuousLinear mixed effects modelShapiro-Wilk, Q-Q plot, Levene’s testMean difference, 95% CI, effect sizeTSKContinuousLinear mixed effects modelShapiro-Wilk, Q-Q plot, Levene’s testMean difference, 95% CI, effect sizeBaseline categorical variablesCategoricalChi-square or Fisher’s exact testNot applicableFrequencies and percentagesBaseline continuous variablesContinuousIndependent t-test or Mann-Whitney U testDistribution assessmentMeans or medians Planned statistical analysis Trial oversight and monitoring Trial oversight will be provided through three complementary structures: a Trial Management Group, an independent Trial Steering Committee, and an independent safety monitor, in line with the greater emphasis in SPIRIT 2025 on clear reporting of harms, oversight, and protocol governance [16]. The Trial Management Group will consist of the principal investigator, the trial coordinator, the treating physiotherapist or physiotherapists, and the data manager. This group will be responsible for day-to-day trial operations, participant recruitment, intervention fidelity, documentation of protocol deviations, and data quality control. The independent Trial Steering Committee will consist of at least three members who are not directly involved in treatment delivery or routine data collection. The committee will oversee trial conduct, review recruitment progress, monitor adherence to the protocol, and advise on any modifications required for scientific, ethical, or operational reasons. An independent safety monitor will review adverse events and serious adverse events as they arise and will advise whether continuation, modification, temporary suspension, or termination of the trial is warranted on safety grounds. Any substantial protocol modification will be submitted to the relevant ethics committee and updated in the trial registration record before implementation, where required. No interim efficacy analysis is planned because the trial is short duration, low risk, and has a modest sample size. The independent safety monitor will review adverse events and serious adverse events, and any decision to modify, suspend, or terminate the trial for safety reasons will be made by the principal investigator in consultation with the Trial Steering Committee and ethics committee where required. Safety measures and adverse effects management Although the planned interventions are considered low risk, all participants will be monitored for adverse events throughout the trial. Expected minor adverse events may include temporary muscle soreness, transient increase in pain, or stretching-related discomfort. Based on the existing literature on low-load stabilization and stretching interventions in low back pain populations, the risk profile of the planned exercise programme is expected to be low, with most adverse effects likely to be minor and transient. Any untoward medical occurrence arising during the intervention period will be recorded in the study adverse event form and reviewed by the principal investigator. Serious adverse events, including events resulting in hospitalization, significant disability, or any medically important condition, will be reported promptly to the ethics committee and the independent safety monitor. Participants experiencing clinically significant worsening of symptoms will be reassessed before further treatment is delivered. Appropriate post-trial clinical support will be provided when required. Dissemination The findings of this trial will be disseminated through peer-reviewed publication, conference presentation, and academic or clinical seminars. The results will also be shared with relevant rehabilitation professionals to support evidence-informed physiotherapy practice for lumbar spondylolisthesis. Authorship of resulting publications will follow accepted international criteria and will reflect substantive contribution to study design, conduct, analysis, and reporting. Discussion This protocol describes a randomized controlled trial designed to determine whether the addition of abdominal hollowing and piriformis stretching exercises to a standardized conventional physiotherapy programme provides superior short-term benefits for adults with low-grade lumbar spondylolisthesis. The study addresses a clinically relevant gap because exercise-based management is commonly recommended for this population, yet important uncertainty remains regarding the value of specific programme components and the extent to which targeted lumbopelvic exercise strategies improve outcomes beyond general physiotherapy care [4, 6]. The proposed intervention is based on a plausible biomechanical and behavioural rationale. Abdominal hollowing is intended to improve activation and coordination of the deep trunk stabilizing system, particularly the transversus abdominis, while also supporting better lumbopelvic control during movement [9, 10]. Improved control of the local stabilizing musculature may reduce excessive segmental loading and pain provocation in people with low-grade vertebral slippage [8, 9]. Piriformis stretching is included because posterior hip tightness may contribute to altered pelvic mechanics, restricted mobility, and movement-related discomfort. Together, these approaches may support more efficient movement, reduced pain, and improved function [11, 13]. The protocol also recognizes the clinical importance of kinesiophobia. In persistent spinal pain conditions, fear of movement may promote activity avoidance, reduce participation in rehabilitation, and sustain disability even when structural pathology is not severe [14, 15]. By measuring kinesiophobia alongside pain and disability, the study will evaluate not only symptom change but also a relevant behavioural mechanism that may influence treatment response [7]. If the experimental programme demonstrates superior improvements in pain, disability, and kinesiophobia compared with standardized conventional physiotherapy alone, the findings will support the clinical effectiveness of adding targeted lumbopelvic exercise components to conservative rehabilitation for low-grade lumbar spondylolisthesis. Such findings may be particularly valuable in resource-constrained settings because the intervention is low-cost, exercise-based, and feasible to implement in routine outpatient physiotherapy practice. Several design choices were made to strengthen methodological transparency in response to known limitations in prior rehabilitation trials. The conventional physiotherapy programme has been standardized to reduce treatment heterogeneity, assessor blinding has been incorporated to limit measurement bias, and intervention fidelity procedures have been specified. The inclusion of a short-term follow-up also improves the ability to assess whether observed benefits persist beyond immediate post-treatment measurement [16]. The study nevertheless has limitations. It is a single-centre trial, which may limit its generalizability to other settings. Treating physiotherapists and participants cannot be fully blinded because of the nature of exercise interventions. In addition, because the protocol focuses on low-grade lumbar spondylolisthesis, the findings may not be directly applicable to more severe or surgically indicated cases. Despite these limitations, the study is expected to provide clinically useful evidence regarding a practical and low-cost rehabilitation strategy that may be particularly relevant in resource-constrained environments [4]. Trial status This protocol is version 2.0, dated 28 March 2026. Participant recruitment has not yet started. Recruitment is expected to begin in April 2026 and to be completed in June 2026. Final post-intervention and follow-up assessments are expected to be completed by August 2026. Supplementary Information Additional file 1: Participant information sheet and informed consent form.Additional file 2: Adverse event reporting form.Additional file 3: SPIRIT checklist. Additional file 1: Participant information sheet and informed consent form. Additional file 2: Adverse event reporting form. Additional file 3: SPIRIT checklist.